Literature DB >> 11519851

Biological behavior and tumorigenesis of subependymal giant cell astrocytomas.

S K Kim1, K C Wang, B K Cho, H W Jung, Y J Lee, Y S Chung, J Y Lee, S H Park, Y M Kim, G Choe, J G Chi.   

Abstract

In spite of the benign nature of subependymal giant cell astrocytomas (SEGAs), some show massive hemorrhage, rapid growth, and tumor recurrence. This led us to investigate the biological behavior, cell dynamics, and tumorigenesis of SEGAs. All patients (4 men and 3 women; age range, 6-27 years; mean, 13.6 years) had features of tuberous sclerosis complex and obstructive hydrocephalus. One patient had intratumoral bleeding. In two patients, sequential neuroimaging showed a subependymal nodule growing to become a SEGA. All underwent surgical resection without radiation therapy. One tumor recurred and was treated surgically. There were no postoperative deaths. The presence of cytologic atypia, mitoses and vascular proliferation had no implication in terms of the clinical course. MIB-1 labeling indices were low (mean, 0.9), indicating low proliferative potential. Unexpectedly, bcl-2 staining was sparse and bax staining predominated in majority of cases. However, the mean value of terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling index was low. Immunohistochemically, tumors were positive for both glial and neuronal markers. In the majority of our cases, the expression of p53 was low. Only one tumor was focally positive for tuberin. SEGAs have low proliferative potential and apoptotic activity, and exhibit features of mixed glial-neuronal differentiation. In contrast to p53, tuberin is suggested to be the tumor suppressor in this tumor.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11519851     DOI: 10.1023/a:1010664311717

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  48 in total

1.  Tuberous sclerosis in a 20-week gestation fetus: immunohistochemical study.

Authors:  S H Park; S H Pepkowitz; C Kerfoot; M J De Rosa; V Poukens; R Wienecke; J E DeClue; H V Vinters
Journal:  Acta Neuropathol       Date:  1997-08       Impact factor: 17.088

2.  Expression of Bax and bcl-2 proteins, regulators of programmed cell death, in human brain tumors.

Authors:  A Hara; Y Hirose; N Yoshimi; T Tanaka; H Mori
Journal:  Neurol Res       Date:  1997-12       Impact factor: 2.448

3.  Localization of tuberous sclerosis 2 mRNA and its protein product tuberin in normal human brain and in cerebral lesions of patients with tuberous sclerosis.

Authors:  C Kerfoot; R Wienecke; M Menchine; J Emelin; J C Maize; C T Welsh; M G Norman; J E DeClue; H V Vinters
Journal:  Brain Pathol       Date:  1996-10       Impact factor: 6.508

4.  Giant cell astrocytoma of the retina in tuberous sclerosis.

Authors:  C E Margo; J P Barletta; J A Staman
Journal:  Retina       Date:  1993       Impact factor: 4.256

5.  Subependymal giant-cell tumor: astrocytic or neuronal?

Authors:  Y Nakamura; L E Becker
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

6.  Tuberous sclerosis in the premature infant: a report of a case with immunohistochemistry on the CNS.

Authors:  T M Chou; S M Chou
Journal:  Clin Neuropathol       Date:  1989 Jan-Feb       Impact factor: 1.368

7.  Identification and characterization of the tuberous sclerosis gene on chromosome 16.

Authors: 
Journal:  Cell       Date:  1993-12-31       Impact factor: 41.582

Review 8.  Tuberous sclerosis-related gene expression in normal and dysplastic brain.

Authors:  H V Vinters; C Kerfoot; M Catania; J K Emelin; S N Roper; J E DeClue
Journal:  Epilepsy Res       Date:  1998-09       Impact factor: 3.045

9.  Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region.

Authors:  F Jin; R Wienecke; G H Xiao; J C Maize; J E DeClue; R S Yeung
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

Review 10.  The 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis.

Authors:  A J Levine; M E Perry; A Chang; A Silver; D Dittmer; M Wu; D Welsh
Journal:  Br J Cancer       Date:  1994-03       Impact factor: 7.640

View more
  20 in total

1.  Enhanced epidermal growth factor, hepatocyte growth factor, and vascular endothelial growth factor expression in tuberous sclerosis complex.

Authors:  Whitney E Parker; Ksenia A Orlova; Gregory G Heuer; Marianna Baybis; Eleonora Aronica; Michael Frost; Michael Wong; Peter B Crino
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

2.  Neurosurgical treatment of subependymal giant cell astrocytomas in tuberous sclerosis complex: a series of 44 surgical procedures in 31 patients.

Authors:  Flavio Giordano; Carla Moscheo; Matteo Lenge; Roberto Biagiotti; Francesco Mari; Iacopo Sardi; Anna Maria Buccoliero; Lorenzo Mongardi; Eleonora Aronica; Renzo Guerrini; Lorenzo Genitori
Journal:  Childs Nerv Syst       Date:  2019-12-18       Impact factor: 1.475

Review 3.  The neurobiology of the tuberous sclerosis complex.

Authors:  Leah Marcotte; Peter B Crino
Journal:  Neuromolecular Med       Date:  2006       Impact factor: 3.843

4.  Management of CNS-related Disease Manifestations in Patients With Tuberous Sclerosis Complex.

Authors:  Darcy A Krueger
Journal:  Curr Treat Options Neurol       Date:  2013-10       Impact factor: 3.598

Review 5.  The molecular biology of WHO grade I astrocytomas.

Authors:  Nicholas F Marko; Robert J Weil
Journal:  Neuro Oncol       Date:  2012-10-22       Impact factor: 12.300

6.  Immunohistochemical study of central neurocytoma, subependymoma, and subependymal giant cell astrocytoma.

Authors:  Heon You; Young Im Kim; Soo Young Im; Haeyoung Suh-Kim; Sun Ha Paek; Sung-Hye Park; Dong Gyu Kim; Hee-Won Jung
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

Review 7.  Subependymal giant cell astrocytoma: current concepts, management, and future directions.

Authors:  Taohui Ouyang; Na Zhang; Thomas Benjamin; Long Wang; Jiantong Jiao; Yiqing Zhao; Jian Chen
Journal:  Childs Nerv Syst       Date:  2014-02-19       Impact factor: 1.475

8.  Congenital subependymal giant cell astrocytoma: clinical considerations and expression of radial glial cell markers in giant cells.

Authors:  Ji Hoon Phi; Sung-Hye Park; Jong Hee Chae; Ki Ho Hong; Sung Sup Park; Ji Hyun Kang; Jong Kwan Jun; Byung-Kyu Cho; Kyu-Chang Wang; Seung-Ki Kim
Journal:  Childs Nerv Syst       Date:  2008-07-16       Impact factor: 1.475

9.  Surgery for subependymal giant cell astrocytomas in children with tuberous sclerosis complex.

Authors:  Martine Fohlen; Sarah Ferrand-Sorbets; Olivier Delalande; Georg Dorfmüller
Journal:  Childs Nerv Syst       Date:  2018-05-15       Impact factor: 1.475

Review 10.  The pathogenesis and imaging of the tuberous sclerosis complex.

Authors:  Henry J Baskin
Journal:  Pediatr Radiol       Date:  2008-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.